Literature DB >> 33987933

Proximal weakness involvement in the first Italian case of Charcot-Marie-Tooth 2CC harboring a novel frameshift variant in NEFH.

Francesco Aruta1, Daniele Severi1, Aniello Iovino1, Emanuele Spina1, Melissa Barghigiani2, Lucia Ruggiero1, Rosa Iodice1, Filippo Maria Santorelli2, Fiore Manganelli1, Stefano Tozza1.   

Abstract

Charcot-Marie-Tooth (CMT) diseases are a clinically and genetically heterogeneous group of disorders. Different variants in the neurofilament heavy chain (NEFH) gene have been described to cause the CMT2CC subtype. Here we report the first Italian patient affected by CMT2CC, harboring a novel variant in NEFH. In describing our patient, we also reviewed previously CMT2CC individuals, and suggested to consider NEFH variant if patients have an axonal sensory-motor neuropathy with a prominent proximal muscles involvement with early requirement of walking aids or wheelchair, remembering a motor neuron disorder.
© 2021 Peripheral Nerve Society.

Entities:  

Keywords:  CMT2CC; NEFH; hereditary neuropathy; proximal weakness

Mesh:

Substances:

Year:  2021        PMID: 33987933     DOI: 10.1111/jns.12454

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  2 in total

1.  Can we identify hereditary TTR amyloidosis by the screening of carpal tunnel syndrome patients?

Authors:  Daniele Severi; Francesco Aruta; Aniello Iovino; Emanuele Spina; Maria Nolano; Fiore Manganelli; Stefano Tozza
Journal:  Neurol Sci       Date:  2022-01-31       Impact factor: 3.830

2.  Charcot-Marie-Tooth disease type 2CC due to NEFH variants causes a progressive, non-length-dependent, motor-predominant phenotype.

Authors:  Menelaos Pipis; Andrea Cortese; James M Polke; Roy Poh; Jana Vandrovcova; Matilde Laura; Mariola Skorupinska; Arnaud Jacquier; Raul Juntas-Morales; Philippe Latour; Philippe Petiot; Guilhem Sole; Yves Fromes; Sachit Shah; Julian Blake; Byung-Ok Choi; Ki Wha Chung; Tanya Stojkovic; Alexander M Rossor; Mary M Reilly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-09-13       Impact factor: 13.654

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.